Rice Hall James & Associates LLC Decreases Stake in Proto Labs, Inc. $PRLB

Rice Hall James & Associates LLC lessened its position in shares of Proto Labs, Inc. (NYSE:PRLBFree Report) by 6.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 114,563 shares of the industrial products company’s stock after selling 7,419 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Proto Labs were worth $5,796,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of PRLB. Horizon Investments LLC increased its position in Proto Labs by 3.4% in the fourth quarter. Horizon Investments LLC now owns 11,886 shares of the industrial products company’s stock worth $601,000 after purchasing an additional 395 shares during the last quarter. Diversified Trust Co. grew its stake in shares of Proto Labs by 4.7% in the 4th quarter. Diversified Trust Co. now owns 10,495 shares of the industrial products company’s stock worth $531,000 after buying an additional 467 shares in the last quarter. Federated Hermes Inc. raised its position in shares of Proto Labs by 1.5% during the 4th quarter. Federated Hermes Inc. now owns 30,748 shares of the industrial products company’s stock valued at $1,556,000 after buying an additional 469 shares in the last quarter. Group One Trading LLC purchased a new position in Proto Labs in the fourth quarter worth about $25,000. Finally, Creative Planning grew its position in Proto Labs by 9.0% in the third quarter. Creative Planning now owns 6,883 shares of the industrial products company’s stock worth $344,000 after acquiring an additional 569 shares in the last quarter. 84.54% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on PRLB shares. Wall Street Zen downgraded Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Monday. Zacks Research raised Proto Labs from a “hold” rating to a “strong-buy” rating in a research report on Monday, May 11th. Finally, Weiss Ratings upgraded Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the stock. According to MarketBeat, Proto Labs currently has an average rating of “Buy” and an average price target of $53.33.

Get Our Latest Analysis on PRLB

Insiders Place Their Bets

In other news, insider Michael R. Kenison sold 16,030 shares of Proto Labs stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $69.49, for a total transaction of $1,113,924.70. Following the completion of the sale, the insider directly owned 18,683 shares in the company, valued at approximately $1,298,281.67. This trade represents a 46.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sven Wehrwein sold 2,000 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total transaction of $154,560.00. Following the sale, the director directly owned 32,505 shares of the company’s stock, valued at $2,511,986.40. This represents a 5.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 25,663 shares of company stock worth $1,804,727. Insiders own 1.30% of the company’s stock.

Proto Labs Price Performance

Shares of NYSE:PRLB opened at $78.48 on Tuesday. The firm has a market capitalization of $1.87 billion, a PE ratio of 74.04 and a beta of 1.39. The business has a 50 day simple moving average of $68.81 and a two-hundred day simple moving average of $60.67. Proto Labs, Inc. has a 1 year low of $37.91 and a 1 year high of $81.29.

Proto Labs (NYSE:PRLBGet Free Report) last issued its quarterly earnings results on Friday, May 1st. The industrial products company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Proto Labs had a return on equity of 4.15% and a net margin of 4.71%.The firm had revenue of $139.34 million for the quarter, compared to the consensus estimate of $135.31 million. During the same period in the prior year, the business posted $0.33 earnings per share. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. Equities research analysts expect that Proto Labs, Inc. will post 1.37 EPS for the current fiscal year.

Proto Labs Company Profile

(Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

Featured Articles

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLBFree Report).

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.